US Capitol Capsule: House user fee bill more costly to US than Senate's, CBO reports
This article was originally published in Scrip
While the US FDA user fee legislation adopted by the Senate on 24 May could potentially save the US millions of dollars in direct spending costs and reduce the deficit, the House version of the bill would actually increase spending and put the nation further in debt, according to a new analysis.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.